Concepedia

Barbra J. Sasu

BJ

28

Publications

1.8K

Citations

20

H-Index

2005

Active since

Affiliations

Allogene Therapeutics (United States)(Current)

Amgen (United States)

Pfizer (United States)

Cellectis (United States)

AIR Worldwide (United States)

Barbra J. Sasu is an author at Allogene Therapeutics (United States) specializing in medicine, hepcidin, and immunology.

ORCID

Top concepts

Publications per year

2005–2023

28

Publications

28

Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia

Barbra J. Sasu, Keegan S. Cooke, Tara Arvedson et al. · Blood · 2010 · 246 citations

Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure

John B. Jordan, Leszek Poppe, Mitsuru Haniu et al. · Journal of Biological Chemistry · 2009 · 215 citations · Full text

Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple Myeloma

Cesar Sommer, Bijan Boldajipour, Tracy C. Kuo et al. · Molecular Therapy · 2019 · 156 citations · Full text

Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT

Sandra L. Ross, Lynn Tran, Aaron Winters et al. · Cell Metabolism · 2012 · 140 citations · Full text

, , +6

A fully human anti-hepcidin antibody modulates iron metabolism in both mice and nonhuman primates

Keegan S. Cooke, Beth Hinkle, Hossein Salimi-Moosavi et al. · Blood · 2013 · 111 citations · Full text

Rows per page

1–5 of 28